Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,213 | 45,479 | 53,060 | 23,850 | 24,847 |
| Receivables | N/A | 1,818 | 1,060 | N/A | 1,435 |
| Inventories | N/A | 1,426 | 637 | N/A | 450 |
| Other current assets | 17,801 | 0 | 0 | 27,013 | 0 |
| TOTAL | $54,188 | $51,122 | $57,321 | $52,100 | $28,521 |
| Non-Current Assets | |||||
| PPE Net | 288 | 532 | 528 | 285 | 589 |
| Intangibles | 15,153 | 37,371 | 37,812 | 15,152 | 37,430 |
| Other Non-Current Assets | 13,040 | 12,942 | 12,946 | 12,951 | 12,952 |
| TOTAL | $28,481 | $50,845 | $51,286 | $28,388 | $50,971 |
| Total Assets | $82,669 | $101,967 | $108,607 | $80,488 | $79,492 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,166 | 4,079 | 3,994 | 3,910 | 4,163 |
| Accounts payable and accrued liabilities | 1,238 | 2,318 | 3,293 | 1,886 | 3,360 |
| Accrued Expenses | 7,329 | 12,923 | 12,149 | 8,885 | 15,292 |
| Other current liabilities | 24,358 | 18,794 | 14,528 | 5,383 | 8,765 |
| TOTAL | $37,091 | $38,114 | $33,964 | $27,233 | $31,586 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,526 | 2,546 | 3,534 | 4,492 | 5,097 |
| Other Non-Current Liabilities | 6,582 | 6,889 | 6,972 | 6,651 | 6,880 |
| TOTAL | $13,161 | $14,488 | $15,559 | $16,196 | $17,047 |
| Total Liabilities | $50,252 | $52,602 | $49,523 | $43,429 | $48,633 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 5 | 4 | 4 |
| Common Shares | 15 | 15 | 15 | 12 | 11 |
| Retained earnings | -259,705 | -241,678 | -226,018 | -215,481 | -207,525 |
| Other shareholders' equity | 151 | 151 | 151 | 151 | 151 |
| TOTAL | $32,417 | $49,365 | $59,084 | $37,059 | $30,859 |
| Total Liabilities And Equity | $82,669 | $101,967 | $108,607 | $80,488 | $79,492 |